First Page | Meta Content | |
---|---|---|
Document Date: 2013-08-29 07:14:54Open Document File Size: 661,16 KBShare Result on FacebookCompanyJohn Wiley & Sons Inc. / Business Communications Company Inc. / Ligand / /CountryUnited States / /CurrencyUSD / /IndustryTermactive site / pharmaceutical scientists / dihydrofolate reductase active site / enzyme active site / chemical transformations / chemical reactions / noncovalent chemical forces / chemical features / biotechnology / catalytic active site / reaction product / protein binding site / pharmaceutical research / structural and chemical requirements / natural products / reversible chemical forces / enzymatic active site / chemical interactions / chemical reaction / pharmaceutical / chemical structure / /MedicalConditionHIV / male pattern baldness Cancer Inflammation Cholesterol lowering Cancer / disease / contraction / pain / Gout Heart disease Inflammation / diseases / infectious organisms / AIDS / infectious diseases / human diseases / /MedicalTreatmentfolk remedies / immunosuppression / drug therapy / /PersonIon Channels / AL CHAPTER / Robert A. Copeland / /ProductCelebrex / Efavirenz / Vioxx / Trimethoprim / Penicillin / Leflunomide / finasteride / Norfloxacin / Digoxin / Acyclovir / Amoxicillin / nevirapine / Viagra / Levitra / Captopril / Allopurinol / Fluorouracil / Omeprazole / Acetazolamide / Lovastatin / Argatroban / /Technologyalpha / Drug Discovery / biotechnology / human genome / /URLwww.bccresearch.com / /SocialTag |